| 000 | 01676 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517032234.0 | ||
| 264 | 0 | _c20150914 | |
| 008 | 201509s 0 0 eng d | ||
| 022 | _a1532-7361 | ||
| 024 | 7 |
_a10.1016/j.surg.2015.04.007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIllum, Henrik | |
| 245 | 0 | 0 |
_aPhase I dose escalation trial of nitroglycerin in addition to 5-fluorouracil and radiation therapy for neoadjuvant treatment of operable rectal cancer. _h[electronic resource] |
| 260 |
_bSurgery _cAug 2015 |
||
| 300 |
_a460-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xtherapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aChemoradiotherapy, Adjuvant _xadverse effects |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFeasibility Studies |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMaximum Tolerated Dose |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 |
_aNitroglycerin _xadministration & dosage |
| 650 | 0 | 4 |
_aRectal Neoplasms _xtherapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aWang, David H | |
| 700 | 1 | _aDowell, Jonathan E | |
| 700 | 1 | _aHittson, William J | |
| 700 | 1 | _aTorrisi, John R | |
| 700 | 1 | _aMeyer, Jeffrey | |
| 700 | 1 | _aHuerta, Sergio | |
| 773 | 0 |
_tSurgery _gvol. 158 _gno. 2 _gp. 460-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.surg.2015.04.007 _zAvailable from publisher's website |
| 999 |
_c24890851 _d24890851 |
||